Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 15 studies | 46% ± 21% | |
ciliated cell | 10 studies | 43% ± 24% | |
oligodendrocyte precursor cell | 7 studies | 27% ± 10% | |
GABAergic neuron | 6 studies | 34% ± 16% | |
glutamatergic neuron | 4 studies | 34% ± 12% | |
ependymal cell | 3 studies | 71% ± 11% | |
interneuron | 3 studies | 50% ± 22% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 27% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 86% | 125.84 | 2271 / 2642 | 94% | 4.96 | 663 / 705 |
bladder | 90% | 178.67 | 19 / 21 | 14% | 0.49 | 71 / 504 |
skin | 83% | 246.04 | 1503 / 1809 | 8% | 0.17 | 40 / 472 |
lung | 70% | 127.30 | 406 / 578 | 20% | 0.57 | 234 / 1155 |
adipose | 82% | 96.38 | 989 / 1204 | 0% | 0 | 0 / 0 |
prostate | 62% | 53.42 | 153 / 245 | 2% | 0.03 | 9 / 502 |
breast | 50% | 38.32 | 231 / 459 | 8% | 0.36 | 91 / 1118 |
thymus | 51% | 27.12 | 331 / 653 | 1% | 0.04 | 8 / 605 |
pancreas | 1% | 0.24 | 3 / 328 | 33% | 0.71 | 59 / 178 |
uterus | 24% | 52.04 | 40 / 170 | 10% | 0.31 | 47 / 459 |
blood vessel | 33% | 19.20 | 444 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 22% | 13.71 | 325 / 1445 | 10% | 0.21 | 19 / 183 |
stomach | 22% | 13.14 | 79 / 359 | 10% | 0.20 | 28 / 286 |
intestine | 15% | 5.95 | 146 / 966 | 7% | 0.17 | 38 / 527 |
adrenal gland | 12% | 9.43 | 30 / 258 | 10% | 1.97 | 22 / 230 |
kidney | 11% | 4.51 | 10 / 89 | 2% | 0.06 | 14 / 901 |
ovary | 6% | 2.51 | 10 / 180 | 7% | 0.16 | 31 / 430 |
liver | 0% | 0 | 0 / 226 | 8% | 1.69 | 33 / 406 |
heart | 3% | 1.30 | 23 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
muscle | 2% | 0.75 | 15 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 0.59 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001662 | Biological process | behavioral fear response |
GO_0050957 | Biological process | equilibrioception |
GO_0000132 | Biological process | establishment of mitotic spindle orientation |
GO_0045475 | Biological process | locomotor rhythm |
GO_0061172 | Biological process | regulation of establishment of bipolar cell polarity |
GO_0005819 | Cellular component | spindle |
Gene name | ANKFN1 |
Protein name | Ankyrin repeat and fibronectin type-III domain-containing protein 1 Ankyrin repeat and fibronectin type III domain containing 1 |
Synonyms | |
Description | FUNCTION: May play a role in neuronal function. . |
Accessions | ENST00000682825.1 [Q8N957-1] ENST00000566473.6 A0A1B0GTR8 ENST00000635860.2 ENST00000318698.6 [Q8N957-2] A0A590UK59 ENST00000653862.1 Q8N957 I3L0N6 ENST00000572945.1 H3BM45 |